Literature DB >> 7707686

Mutation analysis in families with discordant phenotypes of phenylalanine hydroxylase deficiency. Inheritance and expression of the hyperphenylalaninaemias.

P Guldberg1, H L Levy, R Koch, C M Berlin, B Francois, K F Henriksen, F Güttler.   

Abstract

Neonatal hyperphenylalaninaemia caused by mutations in the gene encoding phenylalanine hydroxylase (PAH) represents a wide spectrum of metabolic phenotypes, ranging from classical phenylketonuria (PKU) to mild hyperphenylalaninaemia (MHP). The marked interindividual heterogeneity is due to the expression of multiple PAH mutations in genetic compounds. We have investigated four unusual families in which both PKU and MHP were present. In each family three different mutations in the PAH gene were identified, including two associated with PKU and one associated with MHP. The unexpected outcome of discordant phenotypes within the families described is explained by previously unrecognized parental MHP. By mutation analysis we have also predicted the phenotypical outcome in a hyperphenylalaninaemic infant born to a mother who before pregnancy had been diagnosed as having MHP. Our results demonstrate the utility of nucleic acid analysis in follow-up in PKU screening programmes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7707686     DOI: 10.1007/bf00712004

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  20 in total

Review 1.  Genetic heterogeneity.

Authors:  B Childs; V M Der Kaloustian
Journal:  N Engl J Med       Date:  1968-11-28       Impact factor: 91.245

2.  Atypical phenylketonuria with borderline or normal intelligence.

Authors:  D Y Hsia; M E O'Flynn; J L Berman
Journal:  Am J Dis Child       Date:  1968-08

3.  Clinical and biochemical observations of patients with atypical phenylketonuria.

Authors:  E S Kang; S Kaufman; P S Gerald
Journal:  Pediatrics       Date:  1970-01       Impact factor: 7.124

4.  Causes for high phenylalanine with normal tyrosine in newborn screening programs.

Authors:  J L Berman; G C Cunningham; R W Day; R Ford; D Y Hsia
Journal:  Am J Dis Child       Date:  1969-01

5.  Phenylalanine has no effect on dihydropteridine reductase activity in phenylketonuria fibroblasts.

Authors:  F Guttler; S Kaufman; S Milstien
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

6.  Molecular basis of phenotypic heterogeneity in phenylketonuria.

Authors:  Y Okano; R C Eisensmith; F Güttler; U Lichter-Konecki; D S Konecki; F K Trefz; M Dasovich; T Wang; K Henriksen; H Lou
Journal:  N Engl J Med       Date:  1991-05-02       Impact factor: 91.245

7.  Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis.

Authors:  P Guldberg; K F Henriksen; F Güttler
Journal:  Genomics       Date:  1993-07       Impact factor: 5.736

8.  Molecular basis for nonphenylketonuria hyperphenylalaninemia.

Authors:  E Economou-Petersen; K F Henriksen; P Guldberg; F Güttler
Journal:  Genomics       Date:  1992-09       Impact factor: 5.736

9.  Two missense mutations causing mild hyperphenylalaninemia associated with DNA haplotype 12.

Authors:  E Svensson; R C Eisensmith; B Dworniczak; U von Döbeln; L Hagenfeldt; J Horst; S L Woo
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

10.  Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninemia in southern Europe.

Authors:  P Guldberg; V Romano; N Ceratto; P Bosco; M Ciuna; A Indelicato; F Mollica; C Meli; M Giovannini; E Riva
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

View more
  5 in total

1.  Effect of genotype on changes in intelligence quotient after dietary relaxation in phenylketonuria and hyperphenylalaninaemia.

Authors:  L G Greeves; C C Patterson; D J Carson; R Thom; M C Wolfenden; J Zschocke; C A Graham; N C Nevin; E R Trimble
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

2.  Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations.

Authors:  E Kayaalp; E Treacy; P J Waters; S Byck; P Nowacki; C R Scriver
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

3.  Aberrant phenylalanine metabolism in phenylketonuria heterozygotes.

Authors:  P Guldberg; K F Henriksen; H C Lou; F Güttler
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

4.  Discordant PKU phenotype in one family due to disparate genotypes and a novel mutation.

Authors:  J J Johnston; U Lichter-Konecki; E Wilson; B R Cobb; B M Evans; R E Schnur; L-J C Wong
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

5.  A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype.

Authors:  P Guldberg; F Rey; J Zschocke; V Romano; B François; L Michiels; K Ullrich; G F Hoffmann; P Burgard; H Schmidt; C Meli; E Riva; I Dianzani; A Ponzone; J Rey; F Güttler
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.